CLASS II Device recall · Reported 14 Dec 2022 · FDA Enforcement Report

NextAR Shoulder Surgical Technique recalled by Medacta Usa

Medacta Usa is recalling NextAR Shoulder Surgical Technique, Shoulder NextAR RSA Platform, CT based, distributed in 7 states. The recall was initiated on 27 Oct 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesDocument Reference Code 99.81NEXTAR.12US (for US market only), Revision Numbers: Rev.02 and previous
Quantity recalled14 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0372-2023
FDA event ID
91091
Recalling firm
Medacta Usa, Memphis, TN
Classification
Class II
Status
Terminated
Recall initiated
27 Oct 2022
FDA classified
2 Dec 2022
Reported
14 Dec 2022
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

27 Oct 2022Recall initiated by company
2 Dec 2022Classified by FDA+36 days
14 Dec 2022Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A warning has been added to the Surgical Technique for NextAR Shoulder, advising verification of suitable patient conditions prior to placement of the NextAR Shoulder Target Holder: WARNING Target fixation requires adequate coracoid bone stability. Osteoporosis, weakness of the coracoid process, or other deficiencies, could lead to adverse events including bone fracture. Verify that the coracoid bone and relevant patient conditions are suitable before proceeding.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

NextAR Shoulder Surgical Technique, Shoulder NextAR RSA Platform, CT based computer-assisted surgical navigation platform used to perform a reverse shoulder arthroplasty on the glenoid

Where it was distributed

AL, FL, NH, CO, IL, SC, AR

AlabamaArkansasColoradoFloridaIllinoisNew HampshireSouth Carolina

Stores named: Target

Questions about this recall

Why was it recalled?

A warning has been added to the Surgical Technique for NextAR Shoulder, advising verification of suitable patient conditions prior to placement of the NextAR Shoulder Target Holder: WARNING Target fixation requires adequate coracoid bone stability. Osteoporosis, weakness of the coracoid process, or other deficiencies, could lead to adverse events including bone fracture. Verify that the coracoid bone and relevant patient conditions are suitable before proceeding.

Which lots are affected?

Document Reference Code 99.81NEXTAR.12US (for US market only), Revision Numbers: Rev.02 and previous

Where was it sold?

AL, FL, NH, CO, IL, SC, AR

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Medacta Usa

All 20

Other Hip & Knee Implants recalls

All 3,111